Impact of Membrane Permeability of P-glycoprotein Inhibitors on the Risk Assessment of Intestinal P-glycoprotein-Mediated Drug-Drug Interactions

This publication has 17 references indexed in Scilit:

• Quantification of P-Glycoprotein in the Gastrointestinal Tract of Humans and Rodents: Methodology, Gut Region, Sex, and Species Matter
  Molecular Pharmaceutics, 2021
• Rat intestinal drug permeability: A status report and summary of repeated determinations
  European Journal of Pharmaceutics and Biopharmaceutics, 2019
• Segmental Dependent Transport of Low Permeability Compounds along the Small Intestine Due to P-Glycoprotein: The Role of Efflux Transport in the Oral Absorption of BCS Class III Drugs
  Molecular Pharmaceutics, 2008
• Analysis of Nonlinear and Nonsteady State Hepatic Extraction with the Dispersion Model Using the Finite Difference Method
  Journal of Pharmacokinetics and Biopharmaceutics, 1998
• In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth
  Pharmaceutical Research, 1997
• Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
  Proceedings of the National Academy of Sciences, 1997
• Disposition and bioavailability of the β₁‐adrenoceptor antagonist talinolol in man
  Biopharmaceutics & Drug Disposition, 1995
• A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
  Pharmaceutical Research, 1995
• Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites.
  Proceedings of the National Academy of Sciences, 1989
• Quantitative mechanistic studies in simultaneous fluid flow and intestinal absorption using steroids as model solutes
  International Journal of Pharmaceutics, 1980